WithdrawnEarly Phase 1

Calcipotriol as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA)

Stopped: The IRB was closed without enrolling any participants

United States0Started 2023-08

Plain-language summary

The purpose of this pilot study is to determine if calcipotriol shows potential to be an effective treatment for Central Centrifugal Cicatricial Alopecia (CCCA). This study aims to evaluate calcipotriol due to the possible anti-inflammatory effects that may affect the hair growth cycle.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women who are eighteen years of age or older * biopsy-proven and/or clinical diagnosis of CCCA Stage II-IV * must be on stable treatment without changes for at least 3 months * Subjects will be recruited from outpatient dermatology clinics at the Wake Forest Baptist Health Department of Dermatology. Exclusion Criteria: * Males

What they're measuring

Amount of hairline stabilization

Timeframe: Baseline

Amount of hairline stabilization

Timeframe: Month 2

Amount of hairline stabilization

Timeframe: Month 4

Amount of hairline stabilization

Timeframe: Month 6

Trial details

NCT IDNCT05416320

SponsorWake Forest University Health Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-11

View on ClinicalTrials.gov More Central Centrifugal Cicatricial Alopecia trials